This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Ms Barbee has a passion to reduce the stigma around mentalhealth and promoting increased access to mentalhealth care and education of both clinicians and the general public. She has also served as advisory board participant for Supernus Pharmaceuticals and Axsome Therapeutics. Subscribe Now!
The COMP005 trial is the first phase 3 study of synthetic psilocybin, marking a milestone in psychedelic research for mentalhealth. No unexpected safety issues or imbalance in suicidal ideation were observed between treatment and placebo groups. points (95% CI [-5.7, -1.5]) in change at the primary endpoint.
of patients who were prescribed antipsychotics for their psychiatric illness and had evidence of tardive dyskinesia (TD) had TD recorded properly in their electronic health records, supporting the idea that TD is often underreported and misdiagnosed and, therefore, not treated appropriately.
SHOW MORE The FDA will update ADHD medication labels, warning of weight loss risks in children under 6, urging careful monitoring by health care professionals. Healthcare professionals should monitor weight and growth in young patients on these medications and consider alternative treatments if adverse effects occur.
link] Related Videos Related Content Advertisement May 29th 2025 Treatment Comparison: Somnolence/Sedation With Dopamine Partial Agonists vs D2 Receptor Antagonists Leah Kuntz April 9th 2022 Here's to a Psychedelic Revolution Amir Inamdar MBBS, DNB (Psych), MFPM May 23rd 2025 Looking Ahead to the ASCP Annual Meeting With Joseph F.
1 When evaluating patients, Robinson outlines that “we need to evaluate not only the risk of the medication exposure to the mother and the infant, but the very serious consideration of the untreated mental illness and those effects, which can be quite severe.”
View my complete profile MentalHealth Links A Healthy Place American Psychological Association BringChange2Mind Child Mind Institute Depression Bipolar Support Alliance Depression Health Network Everyday Health Healthline International Bipolar Foundation International Psychoanalysis Modern Psychoanalysis N.A.M.I
View my complete profile MentalHealth Links A Healthy Place American Psychological Association BringChange2Mind Child Mind Institute Depression Bipolar Support Alliance Depression Health Network Everyday Health Healthline International Bipolar Foundation International Psychoanalysis Modern Psychoanalysis N.A.M.I
View my complete profile MentalHealth Links A Healthy Place American Psychological Association BringChange2Mind Child Mind Institute Depression Bipolar Support Alliance Depression Health Network Everyday Health Healthline International Bipolar Foundation International Psychoanalysis Modern Psychoanalysis N.A.M.I
Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. 2022:39(7):1,6-8. N Engl J Med. 1989;321(22):1489-1493. Guidelines. Accessed June 6, 2025. Psychiatric pharmacogenomics: the evidence base. Psychiatric Times. Serum levels of psychiatric drugs. Psychiatric Times. 2014;31(11):64-67.
FDA Indications, Potential Future Indications, and Areas of Investigation for GLP-1 RAs Soon after their introduction, GLP-1 RAs’ significant weight-lowering effects and health benefits in other medical disorders became apparent, with relatively greater metabolic and weight loss benefits reported with newer GLP-1 RAs and dual agonists.
Navigating medication safety during pregnancy can feel overwhelming, especially for women managing mentalhealth conditions. For women with mentalhealth conditions, the decision to use ondansetron requires careful consideration. The rising use of ondansetron for pregnancy-related nausea presents a complex scenario.
McIntyre, MD, FRCPC Key Takeaways Incretin-based treatments, especially GLP-1 RAs, may address comorbidities in mentaldisorders and have direct CNS effects, potentially modifying disease progression. The GLP-1 RAs as Psychiatric Medications? The GLP-1 RAs as Psychiatric Medications? The GLP-1 RAs as Psychiatric Medications?
Shutterstock Generously contributed by Daria and Dmitri Bukhman of Bukhman Philanthropies, the gift will bolster Oxford’s pioneering research and help expand mindfulness-based cognitive therapy – an evidence-based approach that helps people recover from depression, enjoy mentalhealth and flourish.
W ith all the recent coverage of the youth mentalhealth crisis and the role of social media, little attention has been given to the way platforms like TikTok promote certain narratives about mentalhealth—shifting not only the conversation but also the way mentalhealth issues are actually experienced.
Professor Cathy Creswell , from Oxford’s Department of Experimental Psychology and lead for the NIHR ARC OxTV’s mentalhealth across the life course theme, recently visited Chile to establish the project. In February 2023, it was recommended for use in the NHS by the National Institute for Health and Care Excellence (NICE).
I was tremendously excited at the launch to see the latest data in patients with Parkinson’s disease and in children.’ Search NIHR OXFORD HEALTH BIOMEDICAL RESEARCH CENTRE NEWS Please follow the link below to read the news on the NIHR BRC website.
Previously, he received the Administrative Award in 2016 from the American Psychiatric Association, the one-time designation of being a Hero of Public Psychiatry from the Speaker of the Assembly of the APA in 2002, and the Exemplary Psychiatrist Award from the National Alliance for the Mentally Ill in 1991. Louis on Sunday, May 19, 2024.
Albright, a Harvard-trained psychiatrist and founder of Sweetgrass Psychiatry, highlighted the neglected nature of sexual health in psychiatry and the need for better education and open conversations. Additionally, she always warns patients that certain medications could potentially cause sexual health adverse effects.
Steven Moffic, MD, examines death, dying, past lives, and the afterlife, linking them to mentalhealth. Parapsychology's potential impact on mental well-being is highlighted, suggesting therapeutic applications. The exploration encourages consideration of how beliefs about the afterlife influence psychological health.
A Brief Group Social-Belonging Intervention to Improve Mental-Health and Academic Outcomes in BIPOC and First-Generation-to-College Students Erin S. Understanding Ethnoracial Disparities and Advancing MentalHealth Equity Through Clinical Psychological Science: Introduction to Special Issue P. Pritchard, Jennifer L.
Valeria Frighi Dr Frighi was a Senior Clinical Researcher in the Department of Psychiatry and an Honorary Consultant in Endocrinology and Diabetes at Oxford Health NHS Foundation Trust. Her work focused on improving health outcomes for people with intellectual disabilities and those experiencing severe mental illness.
Previously, he received the Administrative Award in 2016 from the American Psychiatric Association, the one-time designation of being a Hero of Public Psychiatry from the Speaker of the Assembly of the APA in 2002, and the Exemplary Psychiatrist Award from the National Alliance for the Mentally Ill in 1991. Louis on Sunday, May 19, 2024.
3 Common examples include health care workers that make ineffective decisions; parents that hurt their children by prioritizing their own needs; careless diving causing an accident; and in terms of our current national protests, second-guessing for the actions after it is over. Psychiatry’s clear essential value is mentalhealth.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content